-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90

Benzinga·04/24/2026 15:38:25
Listen to the news
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $89 to $90.